This is an open-label study to investigate the diagnostic performance of 18F-FDG PET/CT
(positron emission tomography/computed tomography) in evaluation of patients with
IgG4-related disease. A single dose of 18F-FDG will be intravenously injected into patients
with IgG4-related disease before and after treatment.
Phase:
Early Phase 1
Details
Lead Sponsor:
Peking Union Medical College Hospital
Treatments:
Deoxyglucose Fluorodeoxyglucose F18 Immunoglobulin G